This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient has received an initial dose of glatiramer acetate (Copaxone) for relapsing-remitting ... (Read 60 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
on: Jul 23, 2018
A patient has received an initial dose of glatiramer acetate (Copaxone) for relapsing-remitting multiple sclerosis. The nurse notes that the patient appears flushed and anxious and has urticaria.
 
  The patient reports palpitations, chest pain, and a feeling of laryngeal constriction. What will the nurse do?
  a. Obtain an order for epinephrine to treat a hypersensitivity reaction.
  b. Prepare to provide cardiorespiratory support.
  c. Report a possible cardiotoxic episode to the provider.
  d. Stay with the patient until this self-limiting episode passes.

Question 2

A nurse is caring for an older adult patient who has Alzheimer's disease. The patient is taking a cholinesterase inhibitor drug. Which side effects would concern the nurse?
 
  a. Confusion and memory impairment
  b. Dizziness and headache
  c. Nausea, vomiting, and diarrhea
  d. Slowed heart rate and lightheadedness


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

olivia_paige29

  • Sr. Member
  • ****
  • Posts: 334
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: D
About 10 of patients taking glatiramer acetate experience a self-limited postinjection reaction characterized by flushing, palpitations, severe chest pain, anxiety, laryngeal constriction, and urticaria; the episode usually lasts 15 to 20 minutes. No treatment is required, but the nurse should stay with the patient to help alleviate anxiety associated with this reaction. Epinephrine is not indicated. Cardiorespiratory support is not necessary. This does not represent a cardiotoxic reaction.

Answer to Question 2

ANS: D
Cardiovascular effects of cholinesterase inhibitor drugs are uncommon but cause the most concern. Bradycardia and fainting can occur when cholinergic receptors in the heart are activated. Confusion and memory impairment are signs of the disease and are not side effects of the drug. Dizziness, headache, nausea, vomiting, and diarrhea are all expected adverse effects, and although uncomfortable, they do not present an increased risk to the patient.


Yolanda

  • Member
  • Posts: 757
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)

amandanbreshears

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

« previous next »
 

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

When using an interpreter, the nurse should pose questions directly to the patient, not the interpre When using an interpreter, the nurse should pose questions directly to the patient, not the interpre
The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve
Apply direct pressure to the patient’s wound. Apply direct pressure to the patient’s wound.
Promoting Adherence in the Older Adult Patient Promoting Adherence in the Older Adult Patient
A patient with Cushing’s syndrome (A) before and (B) after receiving treatment. Sharmyn McGraw A patient with Cushing’s syndrome (A) before and (B) after receiving treatment. Sharmyn McGraw
Hypothetical Exchanges of Information within the Brain of a Patient with Visual Agnosia Hypothetical Exchanges of Information within the Brain of a Patient with Visual Agnosia
Video: Second Messengers in the Inositol-lipid Signaling Pathway

For a complete list of videos, visit our video library